🇺🇸 FDA
Patent

US 12247059

Conjugates of an IL-2 moiety and a polymer

granted A61KA61K38/2013A61K47/60

Quick answer

US patent 12247059 (Conjugates of an IL-2 moiety and a polymer) held by Nektar Therapeutics expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/2013, A61K47/60, A61P, A61P17/00